Walleye Trading’s MacroGenics MGNX Stock Holding History

Walleye Trading’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5,800	Closed	-$185K	–	5390
2021 Q1	$185K	Buy	+5,800	New	+$141K	﹤0.01%	3700

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Walleye Trading's MGNX Position: Q1 2023 in Review

Walleye Trading sold out of MacroGenics (MGNX) in Q1 2023, closing a stake of 14,584 shares — an estimated $97.9K sold.

Walleye Trading first reported a position in MGNX in Q1 2017 and held it in 4 quarters. The position peaked at $119K in Q1 2022. 137 funds tracked by Wall St. Rank hold MGNX as of Q1 2023.

Walleye Trading reported no remaining MacroGenics position as of Q1 2023 after selling out during the quarter.
Walleye Trading sold 14,584 MacroGenics shares in Q1 2023, an estimated $97.9K.
Walleye Trading first reported a position in MacroGenics in Q1 2017 and held it in 4 quarters.
Walleye Trading's MacroGenics position peaked at $119K in Q1 2022.
137 funds tracked by Wall St. Rank held MacroGenics as of Q1 2023.

Based on Walleye Trading's 13F filing for Q1 2023, filed 15 May 2023.